Faculty Opinions recommendation of Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology.

Author(s):  
Andrew Jenkins
2007 ◽  
Vol 107 (5) ◽  
pp. 756-767 ◽  
Author(s):  
Robert Dickinson ◽  
Brian K. Peterson ◽  
Paul Banks ◽  
Constantinos Simillis ◽  
Juan Carlos Sacristan Martin ◽  
...  

Background Inhibition of N-methyl-D-aspartate (NMDA) receptors by anesthetic gases and vapors may play an important role in anesthesia and neuroprotection. However, the site of action of these agents on the NMDA receptor is unknown. The authors show that xenon and isoflurane compete for the binding of the coagonist glycine on the NMDA receptor NR1 subunit. Methods Using a novel application of grand canonical Monte Carlo simulations, the authors predict the binding site of xenon on NMDA receptors. They test this prediction using electrophysiology on recombinant NMDA receptors. Results The authors' modeling predicts that xenon binds at the glycine site of the NMDA receptor. The authors show that inhibition of NMDA receptors by xenon and isoflurane increases as glycine concentration is decreased, consistent with the prediction of competitive inhibition at the glycine site. Lineweaver-Burk analysis shows that isoflurane inhibition seems purely competitive with glycine, but for xenon, there is an additional component of noncompetitive inhibition. The loss of inhibitory effect of xenon and isoflurane in mutant NR1(F639A)/NR2A receptors is explained by increased glycine affinity of the mutant receptors, and inhibition is restored at low glycine concentrations. Conclusions Xenon and isoflurane inhibit NMDA receptors by binding at the same site as the coagonist glycine. This finding may have important implications for general anesthesia and neuroprotection. Neuroprotectants that act at the glycine site of the NMDA receptor antagonists are well tolerated in patients, being devoid of psychotomimetic side effects, and the mechanism of inhibition may play a role in their clinical profile.


2003 ◽  
Vol 29 (2) ◽  
pp. 300-307 ◽  
Author(s):  
Daniel C Javitt ◽  
Andrea Balla ◽  
Sarah Burch ◽  
Ray Suckow ◽  
Shan Xie ◽  
...  

2019 ◽  
Vol 7 (5) ◽  
pp. 340-348 ◽  
Author(s):  
Salam Pradeep Singh ◽  
Chandrabose Selvaraj ◽  
Bolin Kumar Knowar ◽  
Sanjeev Kumar Singh ◽  
Chingakham Brajakishor Singh ◽  
...  

1999 ◽  
Vol 340 (3) ◽  
pp. 687-692 ◽  
Author(s):  
Jun-ichi MIYAZAKI ◽  
Shigetada NAKANISHI ◽  
Hisato JINGAMI

N-Methyl-D-aspartate receptor channels are composed of an NR1 subunit and at least one of the NR2 subunits (NR2A-D). Activation of the N-methyl-D-aspartate receptor requires the co-agonists glycine and glutamate. It has been proposed that the NR1 subunit possesses a glycine-binding site. We have expressed a soluble form of the NR1 subunit, which was produced by connecting the N-terminal extracellular region with the extracellular loop between the third and fourth membrane segments, by a baculovirus system along with full-length and truncated membrane-bound forms. The soluble NR1 receptor was efficiently secreted into the culture medium and showed a high affinity for ligands. The Kd of a glycine-site antagonist, [3H]MDL 105,519 [(E)-3-(2-phenyl-2-carboxyethenyl)-4,6-dichloro-1H-indole-2-carboxylic acid], for the soluble receptor was 3.89±0.97 nM, which was comparable to the Kd of 4.47±1.39 nM for the membrane-bound full-length form. These values were close to the values reported previously with the use of rat brain membranes and Chinese hamster ovary cells expressing the full-length form of the NR1 subunit. The Ki values of other glycine-site antagonists, L-689,560 (trans-2-carboxy-5,7-dichloro - 4 - phenylaminocarbonylamino - 1,2,3,4 - tetrahydroquinoline), 5,7-dichlorokynurenate and 5,7-dinitroquinoxaline-2,3-dione, for the soluble receptor were also similar to those for the full-length form of NR1. [3H]MDL 105,519 binding was also inhibited by the agonists glycine and D-serine. Thus the affinity and selectivity of ligand-binding characteristics of the NR1 subunit is conferred on the soluble form of the NR1 subunit. This soluble receptor provides a good experimental tool for initiating a biophysical analysis of the N-methyl-D-aspartate receptor channel protein.


1991 ◽  
Vol 1 (9) ◽  
pp. 455-460 ◽  
Author(s):  
Francesco G. Salituro ◽  
Ronald C. Tomlinson ◽  
Bruce M. Baron ◽  
David A. Demeter ◽  
Herschel J.R. Weintraub ◽  
...  

1990 ◽  
Vol 55 (4) ◽  
pp. 1346-1351 ◽  
Author(s):  
L. M. Pullan ◽  
M. Britt ◽  
M. J. Chapdelaine ◽  
R. A. Keith ◽  
D. LaMonte ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document